Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Century Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 50 | +2 |
| Shares | 19.8M | 571.1K | 21.1M | +1.91M (+9.9%) |
| Value | $496.2M | $14.4M | $335.2M | −$146.6M (−30.4%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Century Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 410,800 | $6.51M | 0.03% |
| Deep Track Capital, LP | 250,000 | $3.96M | 0.29% |
| Walleye Capital LLC | 62,471 | $991.0K | 0.03% |
| Goldman Sachs Group Inc | 18,655 | $296.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 15,545 | $246.0K | 0.00% |
| HarbourVest Partners LLC | 14,631 | $232.0K | 0.03% |
| Royce & Associates LP | 12,900 | $205.0K | 0.00% |
| ProShare Advisors LLC | 10,273 | $163.0K | 0.00% |
| Hershey Trust Co | 4,723 | $75.0K | 0.00% |
| Daiwa Securities Group Inc. | 159 | $3.00K | 0.00% |
Sold out (8)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 69,024 | $1.74M |
| Caas Capital Management LP | 30,000 | $755.0K |
| Citadel Advisors LLC | 24,044 | $605.0K |
| Ghisallo Capital Management LLC | 15,000 | $377.0K |
| Rhumbline Advisers | 8,697 | $219.0K |
| SG Americas Securities, LLC | 5,314 | $134.0K |
| MetLife Investment Management | 4,939 | $124.3K |
| Metropolitan Life Insurance Co | 3,737 | $94.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 571,053 | $14.4M |